Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Shares Outstanding (Weighted Average): 2020-2024

Historic Shares Outstanding (Weighted Average) for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $208.7 million.

  • Cellebrite DI's Shares Outstanding (Weighted Average) rose 20.81% to $240.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.4 million, marking a year-over-year increase of 20.81%. This contributed to the annual value of $208.7 million for FY2024, which is 8.95% up from last year.
  • Latest data reveals that Cellebrite DI reported Shares Outstanding (Weighted Average) of $208.7 million as of FY2024, which was up 8.95% from $191.6 million recorded in FY2023.
  • In the past 5 years, Cellebrite DI's Shares Outstanding (Weighted Average) ranged from a high of $208.7 million in FY2024 and a low of $180.2 million during FY2020.
  • In the last 3 years, Cellebrite DI's Shares Outstanding (Weighted Average) had a median value of $191.6 million in 2023 and averaged $194.5 million.
  • Data for Cellebrite DI's Shares Outstanding (Weighted Average) shows a peak YoY climbed of 8.95% (in 2024) over the last 5 years.
  • Over the past 5 years, Cellebrite DI's Shares Outstanding (Weighted Average) (Yearly) stood at $180.2 million in 2020, then remained steady at $180.2 million in 2021, then grew by 1.72% to $183.3 million in 2022, then rose by 4.52% to $191.6 million in 2023, then grew by 8.95% to $208.7 million in 2024.